"Ketanserin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
| Descriptor ID |
D007650
|
| MeSH Number(s) |
D03.383.621.365 D03.633.100.786.830.333
|
| Concept/Terms |
Ketanserin- Ketanserin
- 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione
R-41,468- R-41,468
- R 41,468
- R41,468
- R-41468
- R 41468
- R41468
|
Below are MeSH descriptors whose meaning is more general than "Ketanserin".
Below are MeSH descriptors whose meaning is more specific than "Ketanserin".
This graph shows the total number of publications written about "Ketanserin" by people in this website by year, and whether "Ketanserin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ketanserin" by people in Profiles.
-
Ketanserin as potential additive drug to improve V/Q mismatch in COVID-19? Crit Care. 2020 08 28; 24(1):526.
-
PAR-2 activating peptide-induced stimulation of pregnant rat myometrium contractile activity partly involves the other membrane receptors. Eur J Obstet Gynecol Reprod Biol. 2007 Jan; 130(1):51-9.
-
Pharmacological treatment of postoperative shivering: a quantitative systematic review of randomized controlled trials. Anesth Analg. 2002 Feb; 94(2):453-60, table of contents.